戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 rticle, we demonstrate that the nonclassical peroxisome proliferator 4-phenyl butyric acid is an effi
2 essed the hypothesis that variability in the Peroxisome Proliferator Activated Receptor (PPAR) pathwa
3 e glutathione-S-transferase 4-4 (Gsta4(-/-))/peroxisome proliferator activated receptor alpha (Ppara(
4 esponsive element binding protein 1 (CREB1), peroxisome proliferator activated receptor alpha (PPARA)
5 biogenesis andbeta-oxidation byatRA requires peroxisome proliferator activated receptor delta.
6                         The nuclear receptor peroxisome proliferator activated receptor gamma (PPARga
7 cyte fate in vivo requires activation of the peroxisome proliferator activated receptor gamma (PPARga
8 f human chorionic gonadotropin (hCGbeta) and peroxisome proliferator activated receptor gamma (PPARga
9  chain amino acids (BCAA), and regulation of peroxisome proliferator activated receptor gamma (PPARga
10 ty to activate the nuclear hormone receptor, peroxisome proliferator activated receptor gamma (PPARga
11 e dismutase, mitochondrial KATP channels and peroxisome proliferator activated receptor gamma coactiv
12 ells with and without lipid loading based on peroxisome proliferator activated receptor gamma coactiv
13                                              Peroxisome proliferator activated receptor gamma coactiv
14                                              Peroxisome proliferator activated receptor gamma coactiv
15                                              Peroxisome proliferator activated receptor gamma, coacti
16                                          The peroxisome proliferator activated receptor-alpha (PPARal
17 ect of PERC on bodyweight loss, induction of peroxisome proliferator activated receptor-alpha (PPARal
18 ificant alterations in pathways regulated by peroxisome proliferator activated receptor-gamma (PPARga
19                                              Peroxisome proliferator activated receptor-gamma coactiv
20                              A series of new peroxisome proliferator activated receptors (PPARs) chir
21 , transient receptor potential channels, and peroxisome proliferator activated receptors are also eng
22 enous ligands for cannabinoid and alpha-type peroxisome proliferator-activated (PPAR-alpha) receptors
23                                              Peroxisome proliferator-activated gamma coactivator 1-al
24 s (SVOCs) were competitive ligands for human peroxisome proliferator-activated nuclear receptor gamma
25                             Agonism of human peroxisome proliferator-activated nuclear receptor gamma
26 noma cells and is upregulated by agonists of peroxisome proliferator-activated receptor (PPAR) alpha
27  pregnane X receptor (PXR) [rifampicin], and peroxisome proliferator-activated receptor (PPAR) alpha
28 demonstrates that gemfibrozil, an agonist of peroxisome proliferator-activated receptor (PPAR) alpha,
29 g-mediated activation of the lipid regulator peroxisome proliferator-activated receptor (PPAR) alpha.
30                  We investigated the role of peroxisome proliferator-activated receptor (PPAR) beta/d
31 cts of A1AT-FA were blocked by inhibitors of peroxisome proliferator-activated receptor (PPAR) beta/d
32 tigated whether the nuclear hormone receptor peroxisome proliferator-activated receptor (PPAR) beta/d
33                                          The peroxisome proliferator-activated receptor (PPAR) family
34 analysis revealed that ZFP407 regulates many peroxisome proliferator-activated receptor (PPAR) gamma
35            Consistent with previous studies, peroxisome proliferator-activated receptor (PPAR) gamma
36                                              Peroxisome proliferator-activated receptor (PPAR) gamma
37 bound by the adipocytic transcription factor peroxisome proliferator-activated receptor (PPAR) gamma,
38 f 5' AMP-activated protein kinase (AMPK) and peroxisome proliferator-activated receptor (PPAR), respe
39 a models, we report that CD8(+) TILs enhance peroxisome proliferator-activated receptor (PPAR)-alpha
40 nt receptor potential vanilloid (TRPV)-1 and peroxisome proliferator-activated receptor (PPAR)-alpha.
41                                              Peroxisome proliferator-activated receptor (PPAR)-delta,
42 ipogenesis (+30% Oil Red O stain [ORO], +50% peroxisome proliferator-activated receptor (PPAR)-gamma
43                                              Peroxisome proliferator-activated receptor (PPAR)-gamma
44 chanistic target of rapamycin (mTOR) and the peroxisome proliferator-activated receptor (PPAR)-gamma
45                                   Studies on peroxisome proliferator-activated receptor (PPAR)-gamma
46 gulates a host of target proteins, including peroxisome proliferator-activated receptor (PPAR)-gamma
47                 Many studies have shown that peroxisome proliferator-activated receptor (PPAR)-gamma
48  oxidation is transcriptionally regulated by peroxisome proliferator-activated receptor (PPAR)alpha a
49 s developed as a highly selective inhibitory peroxisome proliferator-activated receptor (PPAR)beta/de
50                                              Peroxisome proliferator-activated receptor (PPAR)gamma a
51 ctly interacts with the transcription factor peroxisome proliferator-activated receptor (PPAR)gamma.
52  into lipid-laden adipocytes by upregulating peroxisome proliferator-activated receptor (PPARgamma) a
53  to a putatively advantageous allele for the peroxisome proliferator-activated receptor A (PPARA) gen
54   Across drug classes, risk was highest with peroxisome proliferator-activated receptor agonists (RR
55 t increased the Gpat4(-/-) BAT expression of peroxisome proliferator-activated receptor alpha (PPAR)
56          Here we show that activation of the peroxisome proliferator-activated receptor alpha (PPAR-a
57 receptor type 1 (CB1) or type 2 (CB2) or via peroxisome proliferator-activated receptor alpha (PPAR-a
58  adipocytes by controlling the expression of peroxisome proliferator-activated receptor alpha (Ppara)
59 such as bezafibrate, known activators of the peroxisome proliferator-activated receptor alpha (PPARal
60 ific DRE that overlaps binding sequences for peroxisome proliferator-activated receptor alpha (PPARal
61                                              Peroxisome proliferator-activated receptor alpha (PPARal
62 atoma FAO cells with Wy14,643, an agonist of peroxisome proliferator-activated receptor alpha (PPARal
63                                  The role of peroxisome proliferator-activated receptor alpha (PPARal
64 phosphorylates serine 73 (Ser(P)(73)) of the peroxisome proliferator-activated receptor alpha (PPARal
65                                      Because peroxisome proliferator-activated receptor alpha (PPARal
66 he interaction and synergy between CREBH and peroxisome proliferator-activated receptor alpha (PPARal
67                                              Peroxisome proliferator-activated receptor alpha (PPARal
68 higher activity of the androgen-induced gene peroxisome proliferator-activated receptor alpha (PPARal
69 tanoic acid (PFOA) increases mouse and human peroxisome proliferator-activated receptor alpha (PPARal
70                          One of these NRs is peroxisome proliferator-activated receptor alpha (PPARal
71 id-lowering drug and a potent agonist of the peroxisome proliferator-activated receptor alpha (PPARal
72 gen species (ROS) activate ligand binding to peroxisome proliferator-activated receptor alpha (PPARal
73                                     In turn, peroxisome proliferator-activated receptor alpha (PPARal
74  and stabilizes the ligand-binding domain of peroxisome proliferator-activated receptor alpha (PPARal
75                         CREBH interacts with peroxisome proliferator-activated receptor alpha (PPARal
76 n, Acot1 knockdown reduced the expression of peroxisome proliferator-activated receptor alpha (PPARal
77 igated whether Astragaloside IV can activate peroxisome proliferator-activated receptor alpha (PPARal
78 ecular analysis unraveled that inhibition of peroxisome proliferator-activated receptor alpha activit
79 interacts with the hepatic nuclear receptors peroxisome proliferator-activated receptor alpha and liv
80  also observed, and we provide evidence that peroxisome proliferator-activated receptor alpha is cons
81  gene is an AMP-activated protein kinase and peroxisome proliferator-activated receptor alpha respons
82                                              Peroxisome proliferator-activated receptor alpha target
83 Falpha (3.0-fold), whereas the expression of peroxisome proliferator-activated receptor alpha target
84 al target of the nuclear receptor PPARalpha (peroxisome proliferator-activated receptor alpha) in bot
85                                              Peroxisome proliferator-activated receptor alpha, a tran
86               A striking increase in nuclear peroxisome proliferator-activated receptor alpha, which
87 ment binding protein-hepatocyte specific and peroxisome proliferator-activated receptor alpha, which
88 y CaMKIIdelta deletion or inhibition, as was peroxisome proliferator-activated receptor alpha.
89 mation and metabolism and are targets of the peroxisome proliferator-activated receptor and liver X r
90                Nuclear receptor co-activator peroxisome proliferator-activated receptor co-activator
91 inked these alterations to downregulation of peroxisome proliferator-activated receptor coactivator 1
92                                We found that peroxisome proliferator-activated receptor delta (PPAR-d
93      Mechanistically, a HFD induces a robust peroxisome proliferator-activated receptor delta (PPAR-d
94                                              Peroxisome proliferator-activated receptor delta (PPARde
95 igand activation of the transcription factor peroxisome proliferator-activated receptor delta (PPARde
96                                              Peroxisome proliferator-activated receptor delta (PPARde
97 Moreover, FAs from higher lipolysis activate peroxisome proliferator-activated receptor delta to indu
98 ant upregulation, in the lung mesenchyme, of peroxisome proliferator-activated receptor gamma (master
99 with markedly diminished ability to activate peroxisome proliferator-activated receptor gamma (MSDC-0
100   We studied interactions between polar bear peroxisome proliferator-activated receptor gamma (pbPPAR
101 action between OmpA and Ecgp96 downregulates peroxisome proliferator-activated receptor gamma (PPAR-g
102  restored expression of the nuclear receptor peroxisome proliferator-activated receptor gamma (PPAR-g
103                                              Peroxisome proliferator-activated receptor gamma (PPAR-g
104 ng through the intracellular butyrate sensor peroxisome proliferator-activated receptor gamma (PPAR-g
105 CL10 and IL-6 transcript levels, and induced peroxisome proliferator-activated receptor gamma (PPAR-g
106 een in a Pten-null background, we identified peroxisome proliferator-activated receptor gamma (Pparg)
107 d their expression of a key adipogenic gene, peroxisome proliferator-activated receptor gamma (Pparg)
108 on of several of its target genes, including peroxisome proliferator-activated receptor gamma (PPARG)
109                                              Peroxisome proliferator-activated receptor gamma (PPARga
110 d the extracellular matrix, particularly the peroxisome proliferator-activated receptor gamma (Pparga
111 pha), C/EBPbeta, C/EBPdelta, KLF5, KLF9, and peroxisome proliferator-activated receptor gamma (PPARga
112                                              Peroxisome Proliferator-Activated Receptor Gamma (PPARga
113 lipid droplet formation and the induction of peroxisome proliferator-activated receptor gamma (PPARga
114 gh levels of TNF and IL-12 but low levels of peroxisome proliferator-activated receptor gamma (PPARga
115 anoparticle (NP) platforms to deliver either Peroxisome Proliferator-Activated Receptor gamma (PPARga
116 ative DNA binding behavior of the adipogenic peroxisome proliferator-activated receptor gamma (PPARga
117  describe here a regulatory circuit in which peroxisome proliferator-activated receptor gamma (PPARga
118 y activation of the nuclear hormone receptor peroxisome proliferator-activated receptor gamma (PPARga
119                                              Peroxisome proliferator-activated receptor gamma (PPARga
120                 Here, we have shown that the peroxisome proliferator-activated receptor gamma (PPARga
121                                              Peroxisome proliferator-activated receptor gamma (PPARga
122  their direct action on the nuclear receptor peroxisome proliferator-activated receptor gamma (PPARga
123                        Long-term exposure to peroxisome proliferator-activated receptor gamma (PPARga
124 ich was recruited to the promoter of Nox1, a peroxisome proliferator-activated receptor gamma (PPARga
125 reduced by concomitant administration of the peroxisome proliferator-activated receptor gamma (PPARga
126                         The nuclear receptor peroxisome proliferator-activated receptor gamma (PPARga
127  such as rosiglitazone and pioglitazone, are peroxisome proliferator-activated receptor gamma (PPARga
128 iated macrophage differentiation by cleaving peroxisome proliferator-activated receptor gamma (PPARga
129 element-binding protein H (CREBH) but not by peroxisome proliferator-activated receptor gamma (PPARga
130    Using mice with a conditional deletion of peroxisome proliferator-activated receptor gamma (PPARga
131                                              Peroxisome proliferator-activated receptor gamma (PPARga
132 tion depends on interactions between Sp1 and peroxisome proliferator-activated receptor gamma (PPARga
133                                              Peroxisome proliferator-activated receptor gamma (PPARga
134  miR-503 expression is directly regulated by peroxisome proliferator-activated receptor gamma (PPARga
135 und that this defect is because of defective peroxisome proliferator-activated receptor gamma (PPARga
136                                              Peroxisome proliferator-activated receptor gamma (PPARga
137                  We have recently shown that peroxisome proliferator-activated receptor gamma (PPARga
138        In contrast, the master adipogenic TF peroxisome proliferator-activated receptor gamma (PPARga
139                                              Peroxisome proliferator-activated receptor gamma (PPARga
140 ancer-binding protein alpha (C/EBPalpha) and peroxisome proliferator-activated receptor gamma (PPARga
141                         The nuclear receptor peroxisome proliferator-activated receptor gamma (PPARga
142                   A class of small molecules-peroxisome proliferator-activated receptor gamma (PPARga
143                  The expression of placental peroxisome proliferator-activated receptor gamma (r = -0
144 ver development by suppressing expression of peroxisome proliferator-activated receptor gamma 2 and l
145 ented the inflammatory response dependent on peroxisome proliferator-activated receptor gamma activit
146 N-terminal kinase inhibitor SP600125 and the peroxisome proliferator-activated receptor gamma agonist
147 lta-prostaglandin J2-dependent activation of peroxisome proliferator-activated receptor gamma and mac
148 ated protein 2 expression and suppression of peroxisome proliferator-activated receptor gamma and p27
149 EM1, increased transcriptional activation of peroxisome proliferator-activated receptor gamma and pro
150 int of communication between the miR-130/301-peroxisome proliferator-activated receptor gamma axis in
151 s, including uncoupling protein 1 (Ucp1) and peroxisome proliferator-activated receptor gamma co-acti
152                            The co-activator, peroxisome proliferator-activated receptor gamma co-acti
153                           Erk5 regulation of peroxisome proliferator-activated receptor gamma co-acti
154                                              Peroxisome proliferator-activated receptor gamma coactiv
155 evels and the expression of four isoforms of peroxisome proliferator-activated receptor gamma coactiv
156 chondrial transcription factor A (TFAM), and peroxisome proliferator-activated receptor gamma coactiv
157 idrug resistance-associated protein 2 and 4, peroxisome proliferator-activated receptor gamma coactiv
158 ated the role of ERK1/2 on the expression of peroxisome proliferator-activated receptor gamma coactiv
159 ets, Myc and the transcriptional coactivator peroxisome proliferator-activated receptor gamma coactiv
160 teins FOXO1, FOXO3A, and FOXO4 and decreased peroxisome proliferator-activated receptor gamma coactiv
161                                 We show that peroxisome proliferator-activated receptor gamma coactiv
162 uction and ATP levels, reduced expression of peroxisome proliferator-activated receptor gamma coactiv
163                                              Peroxisome proliferator-activated receptor gamma coactiv
164 of cyclic guanosine monophosphate (cGMP) and peroxisome proliferator-activated receptor gamma coactiv
165 of p38 MAPK decreased accumulation of active peroxisome proliferator-activated receptor gamma coactiv
166 Thus, we hypothesized that overexpression of peroxisome proliferator-activated receptor gamma coactiv
167                                              Peroxisome proliferator-activated receptor gamma coactiv
168 w here that the transcriptional coactivators peroxisome proliferator-activated receptor gamma coactiv
169 steoblast apoptosis that was associated with peroxisome proliferator-activated receptor gamma coactiv
170 ough AMP-activated protein kinase (AMPK) and peroxisome proliferator-activated receptor gamma coactiv
171 on directly through increased translation of peroxisome proliferator-activated receptor gamma coactiv
172 nd ZR75.1 breast cancer cells, IGF-1 induces peroxisome proliferator-activated receptor gamma coactiv
173 y, which is caused by a rapid degradation of Peroxisome proliferator-activated receptor gamma Coactiv
174                                              Peroxisome proliferator-activated receptor gamma coactiv
175      Here we demonstrate, unexpectedly, that peroxisome proliferator-activated receptor gamma coactiv
176 irisin precursor) and its upstream activator peroxisome proliferator-activated receptor gamma coactiv
177 ssion, potentially through the regulation of peroxisome proliferator-activated receptor gamma coactiv
178                                              Peroxisome proliferator-activated receptor gamma coactiv
179 but was independent of the activation of the peroxisome proliferator-activated receptor gamma coactiv
180 e Huh7, the coexpression of the coactivators peroxisome proliferator-activated receptor gamma coactiv
181 city are known to regulate and interact with peroxisome proliferator-activated receptor gamma coactiv
182 gnature genes uncoupling protein (UCP)-1 and peroxisome proliferator-activated receptor gamma coactiv
183     Here we demonstrate that the coactivator peroxisome proliferator-activated receptor gamma coactiv
184 tably, the mitochondrial DNA copy number and peroxisome proliferator-activated receptor gamma coactiv
185 ouse, these UCP1(+) cells also expressed the peroxisome proliferator-activated receptor gamma coactiv
186                The transcriptional regulator peroxisome proliferator-activated receptor gamma coactiv
187 on of Zfp423, a transcriptional regulator of peroxisome proliferator-activated receptor gamma express
188 that fuses paired box gene 8 (PAX8) with the peroxisome proliferator-activated receptor gamma gene (P
189 CBD enhanced the transcriptional activity of peroxisome proliferator-activated receptor gamma in luci
190 nase 2, 15-deoxy Delta-prostaglandin J2, and peroxisome proliferator-activated receptor gamma in this
191           Finally, application of a specific peroxisome proliferator-activated receptor gamma inhibit
192 BPD that is not dependent on the decrease in peroxisome proliferator-activated receptor gamma levels.
193            Unexpectedly, oxidized fatty acid peroxisome proliferator-activated receptor gamma ligands
194 nsport, possibly through oxidized fatty acid peroxisome proliferator-activated receptor gamma ligands
195 vo, that miR-130/301-specific control of the peroxisome proliferator-activated receptor gamma regulat
196  c-Jun N-terminal kinase, thereby inhibiting peroxisome proliferator-activated receptor gamma through
197         Notably, I148M cells display reduced peroxisome proliferator-activated receptor gamma transcr
198 has shown that phosphorylation of PPARgamma (peroxisome proliferator-activated receptor gamma) at ser
199 nhanced serine 273 phosphorylation of Pparg (peroxisome proliferator-activated receptor gamma).
200 ing STAT3, STAT6, Kruppel-like factor 4, and peroxisome proliferator-activated receptor gamma, and ca
201 he mitochondrial transcriptional coactivator peroxisome proliferator-activated receptor gamma, coacti
202 nd import of the transcriptional coactivator peroxisome proliferator-activated receptor gamma-coactiv
203 tochondrial biogenesis regulator Pgc-1alpha (peroxisome proliferator-activated receptor gamma-coactiv
204 gulating macrophage lipid metabolism through peroxisome proliferator-activated receptor gamma-depende
205 e injections in rats were reported to induce peroxisome proliferator-activated receptor gamma-depende
206 fects thought to be due to activation of the peroxisome proliferator-activated receptor gamma.
207 3(nur12) mice or in mice given inhibitors of peroxisome proliferator-activated receptor gamma.
208  adipogenic differentiation was mediated via peroxisome proliferator-activated receptor gamma.
209 lta-prostaglandin J2-dependent activation of peroxisome proliferator-activated receptor gamma.
210 macologic inhibitors of cyclooxygenase 2 and peroxisome proliferator-activated receptor gamma.
211  phosphatases, and ameliorated activation of peroxisome proliferator-activated receptor gamma/sterol
212 Tfe3, control the regulator of adipogenesis, peroxisome proliferator-activated receptor gamma2 (Pparg
213     Adiponectin receptor agonists, selective peroxisome proliferator-activated receptor modulators, c
214  of inflammatory mediators and repression of peroxisome proliferator-activated receptor signaling and
215 n metabolic pathways, some linked to altered peroxisome proliferator-activated receptor signaling, mu
216 the first week due to failure to undergo the peroxisome proliferator-activated receptor signaling-dep
217 rget soluble epoxide hydrolase (sEH) and the peroxisome proliferator-activated receptor type gamma (P
218                      Activation of the PPAR (peroxisome proliferator-activated receptor)-fatty acid o
219                                              Peroxisome proliferator-activated receptor-alpha (PPARal
220 ing fatty acid beta-oxidation with GW7647, a peroxisome proliferator-activated receptor-alpha (PPARal
221  insulin and mTORC1 signaling was activated, peroxisome proliferator-activated receptor-alpha (PPARal
222             Elafibranor is an agonist of the peroxisome proliferator-activated receptor-alpha and per
223 sepsis and to identify the mechanism whereby peroxisome proliferator-activated receptor-alpha confers
224                                              Peroxisome proliferator-activated receptor-alpha express
225 ant to survival in sepsis than hematopoietic peroxisome proliferator-activated receptor-alpha express
226        We sought to characterize the role of peroxisome proliferator-activated receptor-alpha in seps
227                                              Peroxisome proliferator-activated receptor-alpha is sign
228                                              Peroxisome proliferator-activated receptor-alpha null (P
229 ared with wild-type mice irrespective of the peroxisome proliferator-activated receptor-alpha status
230 gulation of nhr-49 (an ortholog of the human peroxisome proliferator-activated receptor-alpha), and a
231 Expression of the PLIN5 gene is regulated by peroxisome proliferator-activated receptor-alpha, fastin
232 R heterodimer partners, liver X receptor and peroxisome proliferator-activated receptor-alpha, key in
233           These results suggest that altered peroxisome proliferator-activated receptor-alpha-mediate
234                                      Because peroxisome proliferator-activated receptor-beta/delta (P
235                         To determine whether peroxisome proliferator-activated receptor-D (PPARD) cou
236 elpar is a potent, selective agonist for the peroxisome proliferator-activated receptor-delta (PPAR-d
237  growth hormone secretagogue ibutamoren, the peroxisome proliferator-activated receptor-delta agonist
238 me proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-delta.
239 wk with rosiglitazone, a specific agonist of peroxisome proliferator-activated receptor-gamma (PPAR-g
240 the upregulation of the transcription factor peroxisome proliferator-activated receptor-gamma (PPAR-g
241            Some nuclear receptors, including peroxisome proliferator-activated receptor-gamma (PPAR-g
242 reduced food intake and altered signaling by peroxisome proliferator-activated receptor-gamma (PPAR-g
243 n primary cultures, 2) likewise blocked by a peroxisome proliferator-activated receptor-gamma (PPAR-g
244 and transcription of ABCG1 and ABCA1 through peroxisome proliferator-activated receptor-gamma (PPARG)
245 d patients with NAFLD, hepatic expression of peroxisome proliferator-activated receptor-gamma (PPARG)
246                                              Peroxisome proliferator-activated receptor-gamma (PPARga
247  but improvement of insulin resistance using peroxisome proliferator-activated receptor-gamma (PPARga
248 al interactions between prenatal DHA and the peroxisome proliferator-activated receptor-gamma (PPARga
249  X receptors alpha and beta (LXRalpha,beta), peroxisome proliferator-activated receptor-gamma (PPARga
250 ctor for transcription factors including the peroxisome proliferator-activated receptor-gamma (PPARga
251 nes, antidiabetic drugs that are agonists of peroxisome proliferator-activated receptor-gamma (PPARga
252                                              Peroxisome proliferator-activated receptor-gamma (PPARga
253     Here we show that dietary SCFAs induce a peroxisome proliferator-activated receptor-gamma (PPARga
254 D challenge revealed that the mRNA levels of peroxisome proliferator-activated receptor-gamma (PPARga
255 13.1 treatment were associated with enhanced peroxisome proliferator-activated receptor-gamma (PPARga
256 ented and even partially reversed ex vivo by peroxisome proliferator-activated receptor-gamma agonist
257                    Furthermore, we show that peroxisome proliferator-activated receptor-gamma agonist
258  a healthy human (mini-)organ, and show that peroxisome proliferator-activated receptor-gamma agonist
259                                              Peroxisome proliferator-activated receptor-gamma agonist
260                In addition, the up-regulated peroxisome proliferator-activated receptor-gamma and -al
261 ung protein showed significant reductions in peroxisome proliferator-activated receptor-gamma and CD3
262  on the transcription coactivator PGC-1beta (peroxisome proliferator-activated receptor-gamma co-acti
263 cal exercise and thyroid hormone mediate the peroxisome proliferator-activated receptor-gamma coactiv
264       Thyroid hormone promotes expression of peroxisome proliferator-activated receptor-gamma coactiv
265 n of the mitochondrial biogenesis regulators peroxisome proliferator-activated receptor-gamma coactiv
266 ctivated receptor-gamma coactivator 1-alpha, peroxisome proliferator-activated receptor-gamma coactiv
267                                              Peroxisome proliferator-activated receptor-gamma coactiv
268                 Changes in the regulation of peroxisome proliferator-activated receptor-gamma coactiv
269 involving the master mitochondrial regulator peroxisome proliferator-activated receptor-gamma coactiv
270 latory proteins, and herein we identify that peroxisome proliferator-activated receptor-gamma coactiv
271 ke factor 15; myocyte enhancer factor 2, and peroxisome proliferator-activated receptor-gamma coactiv
272  mediated by the transcriptional coactivator peroxisome proliferator-activated receptor-gamma coactiv
273 -related genes and a persistent reduction in peroxisome proliferator-activated receptor-gamma express
274 that an interaction between STAT1, p300, and peroxisome proliferator-activated receptor-gamma is requ
275 4(-/-) macrophages have relatively increased peroxisome proliferator-activated receptor-gamma levels
276 (-/-) OPCs with cholesterol or activation of peroxisome proliferator-activated receptor-gamma with pi
277 ral components of the liver clock, including peroxisome proliferator-activated receptor-gamma, coacti
278 ease of a transferable factor able to induce peroxisome proliferator-activated receptor-gamma-mediate
279 roxynonenal) released from the heart trigger peroxisome proliferator-activated receptor-gamma-mediate
280 vation of arterial NADPH oxidase triggered a peroxisome proliferator-activated receptor-gamma-mediate
281 sed, whereas SREBP-1 interference increased, peroxisome proliferator-activated receptor-stimulated ex
282 one of the three isoforms identified for the peroxisome proliferator-activated receptors (PPARs) and
283                                              Peroxisome proliferator-activated receptors (PPARs) are
284                                              Peroxisome proliferator-activated receptors (PPARs) regu
285                                              Peroxisome proliferator-activated receptors (PPARs) regu
286        Bezafibrate (BEZ), a pan activator of peroxisome proliferator-activated receptors (PPARs), has
287  NRs for treating metabolic diseases are the peroxisome proliferator-activated receptors (PPARs), PPA
288 adelmidrol is dependent on the activation of peroxisome proliferator-activated receptors (PPARs), we
289 th 14 other nuclear receptors, including the peroxisome proliferator-activated receptors (PPARs).
290 PARgamma is one of the three isoforms of the Peroxisome Proliferator-Activated Receptors (PPARs).
291 ese results are consistent with induction of peroxisome proliferator-activated receptors and disrupti
292 et of hypoxia-inducible factor 1 (Hif-1) and peroxisome proliferator-activated receptors.
293 mediated lipolysis to induce the activity of peroxisome proliferator-activated receptors.
294        Here, we investigate allostery in the peroxisome proliferator-activated/retinoid X receptor he
295 al LPS exposure led to pre-existing elevated peroxisome proliferators-activated receptor-gamma co-act
296 biogenesis, autophagy, and the expression of peroxisome proliferator gamma coactivator 1 alpha (PGC-1
297 the well-characterized role of 15d-PGJ2 as a peroxisome proliferator receptor-gamma agonist, its acti
298 , including the liver X receptors (LXRs) and peroxisome-proliferator receptor gamma (PPARgamma).
299      Computational analysis identified three peroxisome proliferator response elements (PPREs) within
300                                          The peroxisome proliferator, WY 14,643 exhibits a pure non-c

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top